Maridea Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-34,887
Closed -$618K 419
2025
Q2
$618K Sell
34,887
-186,768
-84% -$3.64M 0.16% 122
2025
Q1
$4.62M Buy
221,655
+155,228
+234% +$2.94M 1.51% 14
2024
Q4
$1.23M Buy
+66,427
New +$1.28M 0.4% 42

Other funds holding BTAL

Maridea Wealth Management's BTAL Position: Q3 2025 in Review

Maridea Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2025, closing a stake of 34,887 shares — an estimated $618K sold.

Maridea Wealth Management first reported a position in BTAL in Q4 2024 and held it in 3 quarters. The position peaked at $4.62M in Q1 2025. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2025.

  • Maridea Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2025 after selling out during the quarter.
  • Maridea Wealth Management sold 34,887 AGF US Market Neutral Anti-Beta Fund shares in Q3 2025, an estimated $618K.
  • Maridea Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and held it in 3 quarters.
  • Maridea Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $4.62M in Q1 2025.
  • 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2025.

Based on Maridea Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.